There are many reasons, from high insulin prices, limited access, and just not wanting to waste a liquid that costs so much
DSIP appears in Peptides UK catalogues alongside Selank, Semax, Epitalon and other experimental compounds associated with neurological or sleep-related research
Rare hypersensitivity reactions to B12 preparations can occur, which might include systemic symptoms, though joint pain specifically is not typically reported
The peptides development was ultimately discontinued in 2007 after a 24-week Phase III trial failed to demonstrate statistically significant weight loss compared to placebo, though research into its regenerative properties has continued
more exercise makes the body more sensitive to insulins actions
Providers can order labs, track results, and view biomarker trend visualizations directly within the platform